EARLY
CANCER
DETECTION
What if we could reduce delay in detection?
£1500
The cost of the test includes the following:
1) 20 minutes consultation with Dr Saad.
2) Filling the forms.
3) Blood test and courier.
4) Discussing the results.
5) A referral letter IF needed.
Introducing, the HrC test
WHAT IS HrC?
Simple risk assessment test to facilitate early detection of cancer.
Through HrC we can:
Confirm "no risk" of cancer presence (which also indicates no risk of developing cancer within the following one year)
Assess risk of cancer presence which can vary from negligible, low, moderate, to high.
WHAT DOES THE HrC TEST DETECT?
Based on a proprietary blood processing protocol, we enrich a special class of pluripotent stem cells, including cancer stem cells, and use multiple highly-specific markers, including RNA, protein & molecular marker. These markers potentially show up in blood post cancer initiation, and nearly 12-18 months before tumour formation. It is this property of stem cells to mobilise from an implicated organ and come into circulation that gives HrC this potential 12-18 month window for early detection (Stage 0).
HrC assesses risk of cancer presence with 93% accuracy/sensitivity*, and is stage agnostic. This compares very favourably with other standard liquid biopsy tests where accuracy increases with stage of cancer, from 16% @Stage I to over 90% @Stage IV. HrC facilitates early detection by tracking (not predicting) risk of cancer presence. This triggers diagnostic tests to be initiated close to tumour formation.
KEY FEATURES OF HrC TEST
IDEAL FOR
(Smokers, Drinkers, Tobacco consumers, etc.)
*In the indian population
CANCER AT A GLANCE
-
Globally, 50% of cases are detected at Stages Ill or IV!
-
Unfortunate tragedy of cancer is delay between formation of detectable tumour and its actual detection.
-
Current diagnosis is through PET scans, and liquid biopsy which can detect cancer only post formation of a detectable tumour.
Most common types of
CANCER
globally
REALITY OF CANCER DETECTION
Delay occurs because there is no alerting mechanism when a detectable tumour is formed, as symptoms show up much later.
Screening
Detection
Initiation
(Tumerogenesis)
Detectable Tumour
Delay in Detection
UNDERSTANDING THE HrC SCORE
HrC PROCESS FLOW
